These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


190 related items for PubMed ID: 20461469

  • 1. Volume-based parameter of 18)F-FDG PET/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications.
    Lee HY, Hyun SH, Lee KS, Kim BT, Kim J, Shim YM, Ahn MJ, Kim TS, Yi CA, Chung MJ.
    Ann Surg Oncol; 2010 Oct; 17(10):2787-94. PubMed ID: 20461469
    [Abstract] [Full Text] [Related]

  • 2. Continued pemetrexed and platin-based chemotherapy in patients with malignant pleural mesothelioma (MPM): value of 18F-FDG-PET/CT.
    Schaefer NG, Veit-Haibach P, Soyka JD, Steinert HC, Stahel RA.
    Eur J Radiol; 2012 Jan; 81(1):e19-25. PubMed ID: 21129871
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Imaging before and after multimodal treatment for malignant pleural mesothelioma.
    Fiore D, Baggio V, Sotti G, Muzzio PC.
    Radiol Med; 2006 Apr; 111(3):355-64. PubMed ID: 16683083
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The role of positron emission tomography/computed tomography in the diagnosis of pleural diseases.
    Orki A, Akin O, Tasci AE, Ciftci H, Urek S, Falay O, Kutlu CA.
    Thorac Cardiovasc Surg; 2009 Jun; 57(4):217-21. PubMed ID: 19670115
    [Abstract] [Full Text] [Related]

  • 11. Management of malignant pleural mesothelioma.
    West SD, Lee YC.
    Clin Chest Med; 2006 Jun; 27(2):335-54. PubMed ID: 16716822
    [Abstract] [Full Text] [Related]

  • 12. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
    De Giorgi U, Valero V, Rohren E, Dawood S, Ueno NT, Miller MC, Doyle GV, Jackson S, Andreopoulou E, Handy BC, Reuben JM, Fritsche HA, Macapinlac HA, Hortobagyi GN, Cristofanilli M.
    J Clin Oncol; 2009 Jul 10; 27(20):3303-11. PubMed ID: 19451443
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Comparison between PET(-FDG) and computed tomography in the staging of lung cancer. Consequences for operability in 94 patients].
    Prévost A, Papathanassiou D, Jovenin N, Menéroux B, Cuif-Job A, Bruna-Muraille C, Domange-Testard A, Liehn JC.
    Rev Pneumol Clin; 2009 Dec 10; 65(6):341-9. PubMed ID: 19995654
    [Abstract] [Full Text] [Related]

  • 16. The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer.
    Lambrecht M, Deroose C, Roels S, Vandecaveye V, Penninckx F, Sagaert X, van Cutsem E, de Keyzer F, Haustermans K.
    Acta Oncol; 2010 Oct 10; 49(7):956-63. PubMed ID: 20586658
    [Abstract] [Full Text] [Related]

  • 17. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.
    Ann Surg; 2007 Dec 10; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [Abstract] [Full Text] [Related]

  • 18. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2007 Oct 10; 43(9):887-93. PubMed ID: 17207656
    [Abstract] [Full Text] [Related]

  • 19. F-18 FDG PET/CT characterization of talc pleurodesis-induced pleural changes over time: a retrospective study.
    Nguyen NC, Tran I, Hueser CN, Oliver D, Farghaly HR, Osman MM.
    Clin Nucl Med; 2009 Dec 10; 34(12):886-90. PubMed ID: 20139823
    [Abstract] [Full Text] [Related]

  • 20. Does positron emission tomography offer prognostic information in malignant pleural mesothelioma?
    Sharif S, Zahid I, Routledge T, Scarci M.
    Interact Cardiovasc Thorac Surg; 2011 May 10; 12(5):806-11. PubMed ID: 21266493
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.